Mitchell Fane was named assistant professor in the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center.
Idalid Franco, Sophia Kamran, and Anwaar Saeed were named health equity fellows by NRG Oncology, an NCI National Clinical Trials Network group, as a part of the organization’s Health Equity Fellowship Program. Fellows receive an award of $50,000 for two years with an end result of developing a new research protocol within NRG Oncology.
Stand Up To Cancer will fund four teams focused on increasing diversity in early phase cancer clinical trials.
The Sontag Foundation awarded five brain cancer researchers the 2022 Distinguished Scientist Award, a $600,000 grant awarded through a competitive scientific review process.
A partnership between UC Davis Comprehensive Cancer Center, TargaGenix, and Northeastern University will receive nearly $3 million over five years to study pancreatic ductal adenocarcinoma through an NIH R01 grant.
Steffi Oesterreich and Adrian V. Lee, breast cancer researchers at UPMC Hillman Cancer Center and Magee-Womens Research Institute, along with Wendie Berg, professor of radiology at UPMC Magee-Womens Hospital—all from the University of Pittsburgh School of Medicine—received funding from the Breast Cancer Research Foundation.
The Mark Foundation for Cancer Research has given two new Drug Discovery Awards.
Laleh Amiri-Kordestani was named acting associate director for cardio-oncology in the FDA Oncology Center of Excellence. She will also continue her role as the division director for the Division of Oncology 1.
Sven Davisson was named associate director of administration at Louisiana Cancer Research Center.
Moffitt Cancer Center, Weill Cornell Medicine, and the University of North Carolina School of Medicine received a $3.5 million, five-year grant from NCI to improve screening and preventative treatment of cervical cancer for women living with HIV in low-resource countries.
